Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Kaku, Y. Articles by Kokuzawa, J. Search for Related Content PubMed PubMed Citation Articles by Kaku, Y. Articles by Kokuzawa, J.

American Journal of Neuroradiology 25:1403-1408, September 2004
© 2004 American Society of Neuroradiology

INTERVENTIONAL

Factors Predictive of Cerebral Hyperperfusion after Carotid Angioplasty and Stent Placement

Yasuhiko Kaku^a, Shin-ichi Yoshimura^b and Jouji Kokuzawa^b

^a Department of Neurosurgery, Asahi University Murakami Memorial Hospital, Japan
^b the Department of Neurosurgery, Gifu University School of Medicine, Japan

Address reprint requests to Yasuhiko Kaku, MD, Department of Neurosurgery, Asahi University Murakami Memorial Hospital Hashimotochou 3–23, Gifu 500-8523, Japan

BACKGROUND AND PURPOSE: Cerebral hyperperfusion syndrome has been increasingly reported as a complication of carotid angioplasty and stent placement. The aim of the present study was to determine significant predictors of hyperperfusion phenomenon after carotid angioplasty and stent placement.

METHODS: We retrospectively reviewed 30 consecutive patients with unilateral severe carotid stenosis who underwent angioplasty and stent placement. Resting cerebral blood flow (CBF) and cerebral vasoreactivity (CVR) to acetazolamide challenge were quantitatively measured to evaluate cerebral hemodynamic reserve. Split-dose [¹²³I] iodoamphetamine single photon emission CT (SPECT) was performed before and 7 days after carotid angioplasty and stent placement. Technetium-99m hexamethylpropyleneamine oxime (HMPAO) SPECT was performed immediately after the procedure.

RESULTS: Three patients had cerebral hyperperfusion phenomenon immediately after angioplasty and stent placement, as shown by HMPAO SPECT: One developed status epilepticus 2 weeks after the procedure. Significant predictors of hyperperfusion included patient age, pretreatment CVR, and pretreatment asymmetry index ([ipsilateral resting CBF/contralateral resting CBF] x 100). Variables determined not to be significant risk factors included pretreatment resting CBF value, degree of carotid stenosis, and interval from the onset of ischemic symptoms.

CONCLUSION: Significant predictors of hyperperfusion phenomenon after carotid angioplasty and stent placement included patient age, pretreatment CVR, and pretreatment asymmetry index. Pretreatment CBF measurements, including those obtained by quantifying CVR and performing SPECT immediately after the procedure may aid in identifying patients at risk and in initiating careful monitoring and control of blood pressure to prevent hyperperfusion syndrome.

This article has been cited by other articles:

				P. M. Meyers, C. C. Phatouros, and R. T. Higashida Hyperperfusion Syndrome After Intracranial Angioplasty and Stent Placement Stroke, September 1, 2006; 37(9): 2210 - 2211. [Full Text] [PDF]

				M. T. Rezende, L. Spelle, C. Mounayer, M. Piotin, D. G. Abud, and J. Moret Hyperperfusion Syndrome After Stenting for Intracranial Vertebral Stenosis Stroke, January 1, 2006; 37(1): e12 - e14. [Abstract] [Full Text] [PDF]